B. Helfrich
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 16
- HER2/EGFR in Cancer Research 7
- Lung Cancer Research Studies 3
- Peptidase Inhibition and Analysis 3
-
- PI3K/AKT/mTOR signaling in cancer 4
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Paul A. Bunn (17 shared papers)Wilbur A. Franklin (8 shared papers)Daniel C. Chan (4 shared papers)Chan Zeng (3 shared papers)Anna E. Barón (3 shared papers)David Raben (7 shared papers)Lynn E. Heasley (3 shared papers)Fred R. Hirsch (4 shared papers)
- Journals
- Lung Cancer (6 papers)Journal of Clinical Oncology (5 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)International Journal of Hyperthermia (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesItalyCanada
In The Last Decade
B. Helfrich
27 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 85
- Oncology 726
- Cancer Research 294
- Pulmonary and Respiratory Medicine 581
- Molecular Biology 698
- Radiology, Nuclear Medicine and Imaging 193
Countries citing papers authored by B. Helfrich
This map shows the geographic impact of B. Helfrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Helfrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Helfrich more than expected).
Fields of papers citing papers by B. Helfrich
This network shows the impact of papers produced by B. Helfrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Helfrich. The network helps show where B. Helfrich may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Helfrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 205 | |
| 2 | 2013 | 203 | |
| 3 | 2005 | 194 | |
| 4 | 2008 | 193 | |
| 5 | Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. | 1999 | 167 |
| 6 | Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. | 2001 | 131 |
| 7 | Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. | 1996 | 89 |
| 8 | 1989 | 66 | |
| 9 | 2004 | 45 | |
| 10 | Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo. | 1998 | 33 |
| 11 | 2004 | 23 | |
| 12 | 2006 | 13 | |
| 13 | 2002 | 12 | |
| 14 | 2001 | 9 | |
| 15 | 2003 | 7 | |
| 16 | 2004 | 5 | |
| 17 | 2006 | 4 | |
| 18 | 2004 | 3 | |
| 19 | 1997 | 2 | |
| 20 | 2005 | 2 |
About B. Helfrich
B. Helfrich is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), HER2/EGFR in Cancer Research (7 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Lung Cancer Research Studies (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Peptidase Inhibition and Analysis (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Oncology (726 citations), Cancer Research (294 citations), Pulmonary and Respiratory Medicine (581 citations), Molecular Biology (698 citations) and Radiology, Nuclear Medicine and Imaging (193 citations). B. Helfrich has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Paul A. Bunn, Wilbur A. Franklin, Daniel C. Chan, Chan Zeng, Anna E. Barón, David Raben, Lynn E. Heasley, Fred R. Hirsch, Marileila Varella‐Garcia and Ting‐Chao Chou. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, International Journal of Hyperthermia and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.